[{"NetIncomeLoss_1_Q3_USD":-69386000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":2388000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":37.02,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":2708000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":0.0,"Depreciation_3_Q3_USD":459000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":4207000.0,"PaymentsToAcquireInvestments_3_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":48.92,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":757992.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":170668000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":146647000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":39265000.0,"TreasuryStockShares_0_Q3_shares":1994198.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":13098695.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":375000.0,"TreasuryStockValue_0_Q3_USD":54998000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":0.0,"CommonStockSharesIssued_0_Q3_shares":28794567.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":1302000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":130766000.0,"Assets_0_Q3_USD":225256000.0,"ShareBasedCompensation_3_Q3_USD":19832000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":3715000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":4388000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":37.21,"ConvertibleLongTermNotesPayable_0_Q3_USD":272508000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":37.02,"EarningsPerShareBasic_3_Q3_USD":-7.78,"EarningsPerShareBasic_1_Q3_USD":-2.62,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":0.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":26225730.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":26455209.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":36000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":13000.0,"AccountsReceivableNetCurrent_0_Q3_USD":21710000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":27000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"InterestPayableCurrent_0_Q3_USD":4200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":1001831.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":78359000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":25331000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":54813000.0,"RestrictedCash_0_Q3_USD":50000000.0,"IncreaseDecreaseInInventories_3_Q3_USD":17836000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-203989000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-69386000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-30833000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":103672000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1313000.0,"Liabilities_0_Q3_USD":587961000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":7715000.0,"AccruedInvestmentIncomeReceivable_0_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-1096000.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":63046000.0,"AmortizationOfFinancingCosts_3_Q3_USD":1214000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5497000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-206103000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":30282000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":26225730.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":26455209.0,"OtherCostAndExpenseOperating_3_Q3_USD":9142000.0,"OtherCostAndExpenseOperating_1_Q3_USD":5558000.0,"LiabilitiesCurrent_0_Q3_USD":78485000.0,"AccountsPayableCurrent_0_Q3_USD":20745000.0,"SaleOfStockNumberOfSharesIssuedInTransaction_1_Q3_shares":363061.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":440000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":3703938.0,"InterestExpense_3_Q3_USD":32923000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":153672000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":10328000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":3211000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":48000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":2708000.0,"AdditionalPaidInCapital_0_Q3_USD":733524000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":228741.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":912000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":2708000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":817000.0,"NetIncomeLoss_3_Q3_USD":-203989000.0,"InterestExpense_1_Q3_USD":13654000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":2251000.0,"RestrictedCashNoncurrent_0_Q3_USD":50000000.0,"EarningsPerShareDiluted_3_Q3_USD":-7.78,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":14409000.0,"OperatingIncomeLoss_3_Q3_USD":-171102000.0,"OperatingIncomeLoss_1_Q3_USD":-55745000.0,"InventoryNet_0_Q3_USD":33972000.0,"SaleOfStockConsiderationReceivedOnTransaction_1_Q3_USD":4200000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":3068000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":28.06,"PreferredStockValue_0_Q3_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":14.04,"LiabilitiesAndStockholdersEquity_0_Q3_USD":225256000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":10920000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2402000.0,"EarningsPerShareDiluted_1_Q3_USD":-2.62,"OperatingExpenses_3_Q3_USD":234148000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1290000.0,"StockholdersEquity_0_Q3_USD":-362705000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":845000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":0.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":130766000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q3_USD":56000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3703938.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2947780.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1041258000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-151290000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":9322000.0,"OperatingExpenses_1_Q3_USD":70154000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":5069000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211102"}]